Friday, October 11, 2024
HomeNewsLatest Health and Medical NewsBulletin: USA Health Regulators Eye Artificial Intelligence in Healthcare

Bulletin: USA Health Regulators Eye Artificial Intelligence in Healthcare

The United States Food and Drug Administration will hold the first Digital Health Advisory Committee meeting November 20th and 21st 2024 in Gaithersburg, Maryland.

This inaugural committee meeting will centre around total product lifecycle considerations for generative AI-enabled medical devices. The committee will also discuss how generative AI can be integrated into medical devices safely, how to assess their performance and what regulation should be put place to ensure that these devices are safe, effective and useful.

Generation AI

AI is becoming increasingly valuable in assisting medical professionals. Radiologists and ophthalmologists have been testing image recognition capabilities to identify cancers and retinopathy for some years already.

Advances in generative AI have been hailed by some as the first step in a healthcare revolution. While the optimists among us might hope that AI will take the pressure off doctors by streamlining routine tasks, others are concerned. Troubling observations about the reliability of generative AI lead somd to question how private companies will incorporate it into devices.

Currently, generative AI tools like ChatGTP don’t perform well in operations that involve numbers and are prone to hallucinations. That is, when the algorithm can’t find what it expects to find in order to complete the task, it will make something up.

Speaking Up

The meeting will be open to the public. Attendees will have the opportunity to contribute during the open section of the hearing. The deadline for oral presentations during the public comment sessions is October the 25th 2024.

Oral presentations from the public will be heard November 20, 2024, 1 p.m. until 2 p.m. and November 21, 2024, between 9:15 a.m. and 10:45 a.m. at the Holiday Inn Gaithersburg, Two Montgomery Village Ave., Gaithersburg, MD 20879.

The meetings will also be accessible via webcast for those who wish to watch but can’t attend in person.

References

Digital Health Advisory Committee Meeting – Nov. 20-21, 2024. U.S. Food and Drug Administration. Accessed September 30, 2024. https://content.govdelivery.com/accounts/USFDA/bulletins/3b59bb9

Topol EJ. The revolution in high-throughput proteomics and AI. Science. 2024;385(6716):eads5749. doi:10.1126/science.ads5749

Virtual You: How Building Your Digital Twin Will Revolutionize Medicine and Change Your Life. Science. 2024;385(6716):1425-1425. doi:10.1126/science.ads7922

Gow G. Revealing The Dark Side: The Top 6 Problems With ChatGPT And Generative AI In 2024. Forbes. Accessed September 30, 2024. https://www.forbes.com/sites/glenngow/2024/01/28/revealing-the-dark-side-the-top-6-problems-with-chatgpt-and-generative-ai-in-2024/

Joanna Mulvaney PhD
Joanna Mulvaney PhD
Joanna Mulvaney worked as a bench researcher for much of her career before transitioning to science communication. She completed a PhD in developmental biology focusing on cell signaling in cardiogenesis at the University of East Anglia, Norwich, UK, before moving on to study axial skeleton development and skeletal myogenesis at King’s College London and regeneration of auditory cells in the ear at University of California San Diego Medical School, USA and Sunnybrook Research Institute, Toronto, Canada. When it comes to scientific information, her philosophy is: make it simple, make it clear, make it useful.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

ANKTIVA Boosts BCG for Bladder Cancer

The FDA has approved the immunotherapy-boosting drug, ANKTIVA, to be used with the existing immunotherapy drug, Bacillus Calmette-Guerin (BCG). This new therapy is a...

Joke Of The Day

A psychiatrist convinced his patient that she had 120 different personalities. Then billed her insurance company for Group therapy!

RECENT COMMENTS

ADVERTISE WITH US

error: Content is read-only and copy-protected.